Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAFV600E mutation

Am J Hematol. 2021 Aug 1;96(8):E295-E298. doi: 10.1002/ajh.26232. Epub 2021 May 26.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Carbamates / pharmacology
  • Carbamates / therapeutic use*
  • Erdheim-Chester Disease / drug therapy*
  • Female
  • Humans
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics*
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*

Substances

  • Carbamates
  • Sulfonamides
  • encorafenib
  • Proto-Oncogene Proteins B-raf